Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy

Medical Principles and Practice

Volumn 20, Issue 5, 2011, Pages 464-469

  Demir, Kenan ^a   Can, Ilknur ^a   Koc, Fatih ^b   Vatankulu, Mehmet Akif ^a   Ayhan, Selim ^a   Akilli, Hakan ^a   Aribas, Alpay ^a   Alihanoglu, Yusuf ^a   Altunkeser, Bulent Behlul ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Atorvastatin; Atrial fibrillation; Electrical cardioversion

Indexed keywords

AMIODARONE; ATORVASTATIN; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; WARFARIN;

ARTICLE; CARDIOVERSION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LEUKOCYTE COUNT; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CHRONIC DISEASE; ELECTRIC COUNTERSHOCK; FEMALE; FIBRINOGEN; HEALTH STATUS INDICATORS; HEPTANOIC ACIDS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PYRROLES; RECURRENCE; TIME FACTORS; WARFARIN;

EID: 79960494933     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000327674     Document Type: Article

References (27)

1. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation: a major contributor to stroke in the elderly - the Framingham Study. Arch Intern Med 1987; 147: 1561-1564. (Pubitemid 17138836) (Pubitemid 17138836)
2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, le Heuzey JY, Kay GN, Lowe JE, et al: ACC/ AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: 254-257.
3. Nattel S: New ideas about atrial fibrillation: 50 years on. Nature 2002; 415: 219-226. (Pubitemid 34059528) (Pubitemid 34059528)
4. Tamargo J, Caballero R, Delpon E: Pharmacological approach in the treatment of atrial fibrillation. Curr Med Chem 2004; 11: 13-28. (Pubitemid 38081732) (Pubitemid 38081732)
5. Boos CJ, Anderson RA, Lip GYH: Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006; 27: 136-149.
6. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, van Wagoner DR, Psaty BM, Lauer MS, et al: Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010. (Pubitemid 37553570) (Pubitemid 37553570)
7. Anderson JL, Allen Maycock CA, Lappé DL, Crandall BG, Horne BD, Bair TL, Morris SR, Li Q, Muhlestein JB, Intermountain Heart Collaborative Study Group: Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 2004; 94: 1255-1259. (Pubitemid 39469943) (Pubitemid 39469943)
8. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, et al: C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891. (Pubitemid 33139098) (Pubitemid 33139098)
9. Siu CW, Lau CP, Tse HF: Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 2003; 92: 1343-1345.
10. Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, Ravid S: Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003; 92: 1379-1383. (Pubitemid 37532555) (Pubitemid 37532555)
11. Ozaydin M, Varol E, Aslan SM, Kucuktepe Z, Dogan A, Ozturk M, Altinbas A: Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol 2006; 97: 1490-1493.
12. Tveit A, Grundtvig M, Gundersen T, Vanberg P, Semb AG, Holt E, Gullestad L: Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 2004; 93: 780-782. (Pubitemid 38338579) (Pubitemid 38338579)
13. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. (Pubitemid 29084777) (Pubitemid 29084777)
14. Garcia-Fernandez A, Marin F, Mainar L, Roldán V, Martnez JG: Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 2006; 98: 1299-1300. (Pubitemid 44584091) (Pubitemid 44584091)
15. Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT: Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 2005; 128: 3421-3427. (Pubitemid 41698673) (Pubitemid 41698673)
16. Auer J, Weber T, Berent R, Lamm G, Ng CK, Hartl P, Strasser U, Eber B: Use of HMG-coenzyme A-reductase inhibitors (statins) and risk reduction of atrial fibrillation after cardiac surgery: result of the SPPAF study - a randomised placebo-controlled trial (abstract). Eur Heart J 2004; 25(suppl):353.
17. Holm T, Andreassen AK, Ueland T, Kjekshus J, Frøland SS, Kjekshus E, Simonsen S, Aukrust P, Gullestad L: Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Am J Cardiol 2001; 87: 815-818. (Pubitemid 32209111) (Pubitemid 32209111)
18. Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Böhm M: Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 2000; 102: 3104-3110.
19. Lefer DJ: Statins as potent anti-inflammatory drugs. Circulation 2002; 106: 2041-2042.
20. Tamargo J, Caballero R, Gomez R, Nez L, Vaquero M, Delpón E: Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy. Pharmacol Ther 2007; 114: 107-126. (Pubitemid 46509657) (Pubitemid 46509657)
21. Mitchell LB, Powell JL, Gillis AM, Kehl V, Hallstrom AP, AVID Investigators: Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 2003; 42: 81-87. (Pubitemid 36760765) (Pubitemid 36760765)
22. Kumagai K, Nakashima H, Saku K: The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004; 62: 105-111. (Pubitemid 38326816) (Pubitemid 38326816)
23. Merckx L, Tieleman RG, Folkeringa RJ, Yigal MP, Fred HN, Emiel CC, Harry JC: Use of statins is associated with reduced incidence of atrial fibrillation in patients with left ventricular hypertrophy and left atrial dilatation (abstract). Heart Rhythm 2004; 1(suppl 1):S105.
24. Dernellis J, Panaretou M: Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J 2005; 150: 1064.
25. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, di Sciascio G: Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114: 1455-1461. (Pubitemid 44526999) (Pubitemid 44526999)
26. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, et al: Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000; 342: 913-920. (Pubitemid 30177051) (Pubitemid 30177051)
27. Kochiadakis GE, Igoumenidis NE, Marketou ME, Kaleboubas MD, Simantirakis EN, Vardas PE: Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebocontrolled study. Heart 2000; 84: 251-257.